Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Preclinical Development: Overview01:28

Preclinical Development: Overview

6.5K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
6.5K
Clinical Trials: Overview01:11

Clinical Trials: Overview

5.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.5K
Clinical Trials01:16

Clinical Trials

11.2K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
11.2K
Drug Discovery: Overview01:26

Drug Discovery: Overview

13.4K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
13.4K
Clinically Relevant Drug Product Specifications: Methods of Establishment01:29

Clinically Relevant Drug Product Specifications: Methods of Establishment

285
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
285
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

557
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
557

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genomic mutation profile and metabolic alterations in diffuse large B-cell lymphoma with abdominal bulky mass.

Annals of hematology·2025
Same author

Branching-Induced Intermolecular Repulsion Effects Drive Stable and Sustainable Flow Batteries on Condensed Nitroxyl Radicals.

Angewandte Chemie (International ed. in English)·2025
Same author

Correction: Endolymphatic hydrops impairs inner ear uptake and distribution of intratympanically injected gadolinium mixed with dexamethasone in patients with Meniere's disease.

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·2025
Same author

Tocilizumab Monotherapy or Combined With Methotrexate for Rheumatoid Arthritis: A Randomized Clinical Trial.

JAMA network open·2025
Same author

Prevalence of and risk factors for important comorbidities of systemic lupus erythematosus using data from a multicenter Chinese cohort registry: A cross-sectional study.

Clinical rheumatology·2025
Same author

Overexpression of the <i>Glycyrrhiza uralensis</i> Phenylalanine Ammonia-Lyase Gene <i>GuPAL1</i> Promotes Flavonoid Accumulation in <i>Arabidopsis thaliana</i>.

International journal of molecular sciences·2025

Related Experiment Video

Updated: Apr 8, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

11.5K

RS3PE: Clinical and Research Development.

Hongbin Li1, Roy D Altman, Qingping Yao

  • 1The Division of Rheumatology, Inner Mongolia Medical University, Hohhot, China.

Current Rheumatology Reports
|June 27, 2015
PubMed
Summary
This summary is machine-generated.

Remitting seronegative symmetrical synovitis with pitting edema (RS3PE) is a rare rheumatic syndrome in the elderly. It can be linked to cancer and responds well to glucocorticoids, offering a good prognosis when malignancy is absent.

More Related Videos

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
09:29

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on: September 30, 2016

14.6K
Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
07:40

Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis

Published on: March 20, 2021

18.8K

Related Experiment Videos

Last Updated: Apr 8, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

11.5K
Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
09:29

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on: September 30, 2016

14.6K
Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
07:40

Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis

Published on: March 20, 2021

18.8K

Area of Science:

  • Rheumatology
  • Geriatric Medicine
  • Oncology

Background:

  • Remitting seronegative symmetrical synovitis with pitting edema (RS3PE) is a rare rheumatic syndrome primarily affecting the elderly.
  • While sharing some clinical features with elderly-onset rheumatoid arthritis and polymyalgia rheumatica, RS3PE presents distinct characteristics.
  • RS3PE is increasingly recognized for its association with neoplasia, suggesting a potential paraneoplastic etiology and heterogeneity.

Purpose of the Study:

  • To summarize the distinct clinical features of RS3PE.
  • To explore potential associations with neoplasia and other rheumatic conditions.
  • To discuss the pathogenesis and treatment outcomes of RS3PE.

Main Methods:

  • Literature review of RS3PE cases.
  • Comparison of clinical manifestations with related rheumatic syndromes.
  • Analysis of potential etiological factors including neoplasia, vascular endothelial growth factor, and infection.
  • Evaluation of treatment response, particularly to glucocorticoids.

Main Results:

  • RS3PE is characterized by synovitis and pitting edema, primarily in elderly individuals.
  • Distinct clinical features differentiate RS3PE from elderly-onset rheumatoid arthritis and polymyalgia rheumatica.
  • Associations with malignancy and other rheumatic conditions suggest RS3PE's heterogeneous and potentially paraneoplastic nature.
  • Limited data suggests a role for vascular endothelial growth factor and infection in RS3PE pathogenesis.
  • Patients without malignancy show a favorable response to low-dose glucocorticoids with a good prognosis.

Conclusions:

  • RS3PE is a distinct elderly-onset rheumatic syndrome with potential paraneoplastic features.
  • Early recognition and management, especially in the absence of malignancy, lead to favorable outcomes with glucocorticoid therapy.
  • Further research is needed to elucidate the heterogeneous pathogenesis of RS3PE.